Allergan reports success in late-stage acne trials

28th March 2017 Uncategorised 0

Dublin, Ireland-based drugmaker Allergan and US partner Paratek Pharmaceuticals have reported that two Phase III trials assessing sarecycline for the treatment of moderate to severe acne have hit their primary endpoints.

More: Allergan reports success in late-stage acne trials
Source: News